GO
Loading...

Eli Lilly and Co

More

  • CHICAGO, June 6- A new way of evaluating tumors may soon help cancer patients identify the underlying genetic link to their disease- and the best possible treatment- all in a single test. "We really are moving away from this one drug, one biomarker, one companion diagnostic," said Dr Richard Pazdur, the U.S. Food and Drug Administration's oncology chief.

  • BRUSSELS/ OTTAWA, June 2- Canada and the European Union are struggling to finalize a multibillion-dollar trade pact six months after political leaders said it was sealed, an embarrassment for Brussels as it seeks a far bigger deal with the United States.

  • ZURICH, June 2- Roche is betting the same tools that made it the world's largest producer of cancer drugs will help it tackle the growing public health crisis of antibiotic resistance as regulators and politicians encourage fresh research.

  • BRUSSELS/ OTTAWA, June 2- Canada and the European Union are struggling to finalize a multi-billion dollar trade pact six months after political leaders said it was sealed, an embarrassment for Brussels as it seeks a far bigger deal with the United States.

  • Early movers: BRCM, MYL, GOOG, Z & more Monday, 2 Jun 2014 | 7:37 AM ET
    Traders on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • May 31- Eli Lilly and Co's cancer drug ramucirumab modestly extended survival in a large, late-stage study of patients with advanced, nonsmall cell lung cancer who had relapsed following initial treatment, according to data presented on Saturday.

  • Erectile drug moves closer to over the counter Thursday, 29 May 2014 | 8:50 AM ET

    Men with ED may be able to avoid the awkwardness of a doctor's visit by buying Cialis without a prescription, under a new proposal. NYT reports.

  • COPENHAGEN, May 28- Danish drugmaker Novo Nordisk, the world's biggest insulin producer, said on Wednesday it had decided to launch its diabetes drug Tresiba in Germany on May 1 after seeing signs of a more favourable pricing situation there.

  • Early movers: AGN, VRS, GE, GOOG & more Wednesday, 28 May 2014 | 7:37 AM ET

    Some of the names on the move ahead of the open.

  • Sanofi, Lilly pursue Cialis over-the-counter approval Wednesday, 28 May 2014 | 2:10 AM ET

    PARIS, May 28- Sanofi and Eli Lilly and Co have agreed to pursue regulatory approval for over-the-counter sales of erectile dysfunction treatment Cialis, the French and U.S. drugmakers said in a statement on Wednesday.

  • Why Pfizer should try to buy Bristol-Myers Tuesday, 27 May 2014 | 1:21 PM ET
    Viagra made by Pfizer and Nexiam made by AstraZeneca.

    What's next for Pfizer, now that its bid for AstraZeneca has been laid to rest, at least temporarily. Analysts weigh in with their views.

  • Chinese city targets pharma firms in graft crackdown Tuesday, 27 May 2014 | 9:08 AM ET

    SHANGHAI, May 27- China's eastern city of Hangzhou is cracking down on graft in the healthcare sector, according to an internal memo from the local government, putting more pressure on global drugmakers operating in the country.

  • A bitter pill as China crackdowns squeeze pharma margins Saturday, 24 May 2014 | 10:00 PM ET

    China has been a magnet for the big global pharmaceutical companies and other healthcare firms as growth slows in Europe and the United States. While global drugmakers withhold their China profit figures, the analysis suggests profit growth is harder to come by- a concern as many global firms look to China as a future growth driver.

  • *China anti-trust watchdog visits Roche office. *China cracking down on wider pharma sector. SHANGHAI/ ZURICH, May 22- Swiss drugmaker Roche Holding AG said it had been visited by a unit of China's anti-trust regulator- a move that comes amid a widening crackdown on corruption and high prices in the country's pharmaceutical sector.

  • SHANGHAI, May 18- Chinese corruption charges against executives of British drugmaker GlaxoSmithKline Plc could be just the start of the pharmaceutical industry's problems in its biggest emerging drugs market, according to industry sources in China.

  • Midday movers: NFLX, PCLN, BIIB & more Thursday, 15 May 2014 | 12:23 PM ET
    NYSE exchange floor

    Take a look at some of Thursday's midday movers:

  • SHANGHAI, May 15- GlaxoSmithKline Plc executive Mark Reilly had little inkling he would be charged with leading a network of corruption in China's pharmaceutical industry, two sources with ties to the businessman and knowledge of the investigation said.

  • Eli Lilly loses UK Alimta patent case to Actavis Thursday, 15 May 2014 | 7:07 AM ET

    LONDON, May 15- Eli Lilly said on Thursday it had lost a patent case in the English High Court over its blockbuster Alimta lung cancer drug to generic drugmaker Actavis.

  • SHANGHAI, May 15- GlaxoSmithKline Plc executive Mark Reilly had little inkling he would be charged with leading a network of corruption in China's pharmaceutical industry, two sources with ties to the businessman and knowledge of the investigation said.

  • This year, at ASCO, all eyes are on pharma Wednesday, 14 May 2014 | 3:41 PM ET

    Some stocks moved after the bell after abstracts for the American Society of Clinical Oncology meeting dropped Wednesday.